It is currently Wed Apr 26, 2017 8:53 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

The Aspen Health Forum October 3-6, 2007.

Scott Johnson, president of the Myelin Repair Foundation, is scheduled to speak at The Aspen Health Forum October 3-6, 2007.

The Aspen Health Forum will explore the most challenging issues and exciting developments in medical science — and how they may affect our individual health and that of our families and communities. The forum will shed light on the state-of-the-art and frontiers of biomedicine. It is a rare opportunity to exchange ideas and socialize with ...
Read more : The Aspen Health Forum October 3-6, 2007. | Views : 1437 | Replies : 0 | Forum : General Discussion


The role of the BBB

New report on BBB from Eurekalert:

Public release date: 5-Apr-2007


Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University

Jefferson immunology researchers show blood-brain barrier damage could affect MS severity
(PHILADELPHIA) -- Immunology researchers at the Kimmel Cancer Center at Jefferson studying a multiple sclerosis (MS)-like disease in mice have shown that the amount of "damage" to the central nervous system’s ...
Read more : The role of the BBB | Views : 4451 | Replies : 29 | Forum : General Discussion


MBP8298

Another hurdle cleared...



BioMS Medical's pivotal multiple sclerosis trial receives positive interim safety analysis

Thursday April 5 -- CNW -- BioMS Medical today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's pivotal phase II/III MAESTRO-01 trial of MBP8298 in patients with secondary progressive MS has completed a planned interim safety analysis and recommended that the trial continue as per the protocol.

This interim analysis was based upon an assessment of the ...
Read more : MBP8298 | Views : 1587 | Replies : 0 | Forum : Drug Pipeline


Social Security Reform News

Last week, The Multiple Sclerosis Foundation published a story regarding my petition initiative to change the way Social Security Disability benefits are awarded to victims of MS and other chronically disabling illnesses. They are also running a full page article about this important effort in the next issue of their quarterly magazine, MSFocus. To date, the petition has been signed by over 1,000 MS patients, physicians, MS advocacy group leaders and members and other concerned ...
Read more : Social Security Reform News | Views : 1396 | Replies : 0 | Forum : General Discussion


Check your mate on this one.

On Tues. my wife and I took our daughter to see a specialist in Juvenile Rheumatoid Arthritis. She has been experiencing some joint pain and her AnA test came back elevated. On top of this she also has shingles. All this and she is only 9 years old. Lupus was also a possibility. After checking her out physically, he said she didn't seem to have enough symptoms to diagnose either RA of Lupus. She did ...
Read more : Check your mate on this one. | Views : 1679 | Replies : 4 | Forum : General Discussion


I eliminated my post

I eliminated my post
Read more : I eliminated my post | Views : 3197 | Replies : 12 | Forum : Antibiotics


Tovaxin update

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin(TM) for Multiple Sclerosis
03 April 2007

Opexa Therapeutics, Inc, a company involved in the development and commercialisation of cell therapies, today announced positive top-line data in an open-label Phase I/II dose escalation clinical trial of the investigational T-cell vaccine, Tovaxin(TM), for multiple sclerosis. In this one-year, 10-subject dose escalation clinical trial, Tovaxin therapy was shown to be safe and effective. ...
Read more : Tovaxin update | Views : 1878 | Replies : 3 | Forum : Drug Pipeline


Article

This article is about Tysabri but covers other issues - like debunking the idea that there is no damage during remissions and some stuff on imaging.

Ian

http://c.moreover.com/click/here.pl?j872355537&w=464753
Read more : Article | Views : 1478 | Replies : 1 | Forum : General Discussion


Considering Tysabri

Hi Everybody,

I'm thinking about Tysabri, see my doctor on 04/18. I'm eligible for it, checked yesterday with my insurance company. According to them, they could have it set up and sent out to my doctor in 3 business days!

I know the history of T, and my drug history... my tentative plan is, if it works, then take it for 1-2 years until we have the next super-duper drug available with less known bad ...
Read more : Considering Tysabri | Views : 10145 | Replies : 40 | Forum : Tysabri (Antegren or Natalizumab)


dose escalation results

April 03, 2007 07:00 AM Eastern Daylight Time
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with TovaxinTM for Multiple Sclerosis
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II dose escalation clinical trial of the investigational T-cell vaccine, Tovaxin™, for multiple sclerosis. In this one-year, 10-subject dose escalation clinical trial, ...
Read more : dose escalation results | Views : 3094 | Replies : 10 | Forum : Tcelna (Tovaxin)


 

Login  •  Register


Statistics

Total posts 237630 • Total topics 25820 • Total members 17097


Contact us | Terms of Service